Occurrence of non- (NCAC) species that are associated with elevated MIC values and therapeutic failures are increasing. As a result, timely and accurate means of identification to the species level is becoming an essential part of diagnostic practices in clinical settings. In this study, 301 clinically isolated yeast strains recovered from various anatomical sites [Blood ( = 145), other sites ( = 156)] were used to assess the accuracy and practicality of API 20C AUX and 21-plex PCR compared to MALDI-TOF MS and large subunit rDNA (LSU rDNA). MALDI-TOF MS correctly identified 98.33% of yeast isolates, 100% of top five species, 95.7% of rare yeast species, while 1.3% of isolates were misidentified. API 20C AUX correctly identified 83.7% of yeast isolates, 97.2% of top five species, 61.8% of rare yeast species, while 16.2% of yeast isolates were misidentified. The 21-plex PCR, accurately identified 87.3% of yeast isolates, 100% of top five species, 72% of rare yeast species, but it misidentified 1.3% of rare yeast species while 9.9% of whole yeast isolates were not identified. The combination of rapidity of 21-plex PCR and comprehensiveness of API 20C AUX, led to correct identification of 92% of included yeast isolates. Due to expensiveness of MALDI-TOF MS and sequencing, this combination strategy could be the most accurate and inexpensive alternative identification strategy for developing countries. Moreover, by the advent and development of cost-effective, reliable, and rapid PCR machines that cost 130 US dollars, 21-plex could be integrated in routine laboratories of developing and resource-limited countries to specifically identify 95% causative agents of yeast-related infections in human. Databases of MALDI-TOF MS, API 20C AUX, and the number of target species identified by 21-plex require further improvement to keep up with the diverse spectrum of yeast species.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385604PMC
http://dx.doi.org/10.3389/fcimb.2019.00021DOI Listing

Publication Analysis

Top Keywords

api 20c
24
20c aux
24
yeast species
24
yeast isolates
24
21-plex pcr
20
rare yeast
16
yeast
13
species
12
top species
12
pcr api
8

Similar Publications

Article Synopsis
  • - Lodderomyces elongisporus, first isolated in 1952 and misidentified as Candida parapsilosis, has gained recognition as a significant human pathogen since the 1970s, with its identification solidified through advances in DNA sequencing.
  • - The review outlines the history of L. elongisporus infections, effective treatment strategies, environmental contamination cases, and a critical evaluation of diagnostic methods, including culture-based techniques and molecular tools like ITS-DNA sequencing.
  • - Emphasizing the importance of accurate identification in vulnerable populations, the review calls for more research to create accessible diagnostic tools to improve understanding and patient outcomes for this emerging pathogen.
View Article and Find Full Text PDF

Purification, structural characterization, and bioactive properties of exopolysaccharides from HD-01.

Front Bioeng Biotechnol

August 2024

Engineering Research Center of Agricultural Microbiology Technology, Ministry of Education, Heilongjiang Provincial Key Laboratory of Plant Genetic Engineering and Biological Fermentation Engineering for Cold Region, Key Laboratory of Microbiology, College of Heilongjiang Province, School of Life Sciences, Heilongjiang University, Harbin, China.

Exopolysaccharides (EPSs), which show excellent biological activities, like anti-tumor, immune regulation, and anti-oxidation activities, have gained widespread attention. In this study, an EPS-producing HD-01 was identified based on 18S rDNA sequence analysis and an API 20C test. The purified HD-01 EPS was obtained by gel filtration chromatography.

View Article and Find Full Text PDF

Background: Recent reports of the emergence of fluconazole resistance in Candida parapsilosis species complex poses a challenge, more specifically in settings where echinocandin-based treatment regime is not feasible.

Objective: This study reported emergence of fluconazole resistance in C. parapsilosis species complex strains isolated from blood cultures.

View Article and Find Full Text PDF

Chlorpyrifos (CP), a widely used pesticide, and its metabolite 3,5,6-trichloro-2-pyridinol (3,5,6-TCP), are xenobiotic compounds detected in many biomes, notably in marine sediments, all over the world. These compounds are posing a serious environmental and health problem given their toxicity to wildlife and possible exposure effects to human neurodevelopment. Microorganisms at CP-impacted environments could harbor metabolic capabilities that can be used as indicators of the biological effects of the contaminant and could encode selected functions reactive against contaminants.

View Article and Find Full Text PDF

Isolation of Candida auris in Clinical Specimens.

Methods Mol Biol

June 2022

Medical Mycology Unit, Department of Microbiology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India.

Article Synopsis
  • Candida auris is a multidrug-resistant yeast that causes serious bloodstream infections, complicating its identification due to issues with misidentification and slow diagnostic methods.
  • New methods like CHROMagar™ Candida Plus and molecular techniques such as PCR and sequencing have improved the ability to accurately identify C. auris in clinical samples.
  • Although some traditional systems struggle with this identification, advancements in molecular diagnostics show promise for faster and more reliable detection.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!